是否AMPK是肝细胞癌的潜在治疗标?
Guo Chen1, Ming-Yuan Li1, Jing-Yi Yang2
1Department of Oncology, Anhui Hospital, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine Hefei, Anhui, China.
AMP激活蛋白激酶 (AMPK) 在细胞能量平衡中起着关键作用,在肝细胞癌 (HCC) 的发展中至关重要. 向AMPK为HCC治疗提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 由于其高复发率和低生存率而带来了重大挑战.
- 目前的化疗和放射治疗等治疗方法由于耐药性和成本效益而面临局限性.
- AMP激活蛋白激酶 (AMPK) 调节细胞能量代谢,影响细胞生长,增殖和存活.
研究的目的:
- 审查了解AMPK在HCC发生和发展中的监管作用的最新进展.
- 探索AMPK在HCC中的分子机制和治疗潜力.
主要方法:
- 对AMPK结构,激活及其与癌症的关系的当前文献的综述.
- 分析AMPK在HCC.病变发生过程中的多方面的作用.
- 讨论AMPK向疗法的转化影响和挑战.
主要成果:
- 详细介绍了AMPK的分子结构和激活机制.
- 确定了与AMPK和瘤进展相关的新兴调节剂.
- 阐明了AMPK在HCC发育和进展中的多种功能.
结论:
- AMPK显著影响HCC的发生,发展和预后.
- 向AMPK为HCC治疗提供了一个有希望和特定的治疗途径.
- 对AMPK向疗法的进一步研究是有必要的,以克服现有的治疗挑战.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
